Mitsu Chem Plast Limited has successfully conducted a virtual analysts and institutional investors meeting, as announced through its regulatory filing to BSE Limited. The meeting represents part of the company's ongoing investor engagement activities and regulatory compliance efforts.

Meeting Details and Format

The analysts and institutional investors meeting took place as scheduled with specific parameters outlined by the company:

Regulatory Compliance and Information Sharing

The company maintained strict adherence to regulatory protocols during the investor interaction. Mitsu Chem Plast Limited specifically noted that the meeting followed a question-and-answer format, ensuring structured communication with participants. Importantly, the company confirmed that no Unpublished Price Sensitive Information (UPSI) was shared during any of the interactions, demonstrating compliance with SEBI regulations.

Corporate Communication and Transparency

The meeting outcome was communicated to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing followed the company's earlier intimation dated March 10, 2026, which had announced the scheduled meeting. The company has made the meeting information available on its official website at www.mitsuchem.com , ensuring transparency and accessibility for all stakeholders.

Company Operations Overview

Mitsu Chem Plast Limited operates from its registered office in Mumbai and maintains three manufacturing units in Maharashtra. The company specializes in various molding technologies including blow molding, injection molding, and custom molding. Its product portfolio encompasses industrial containers, furniture parts, automotive parts, and medical devices, serving diverse industry segments.

Mitsu Chem Plast Limited has achieved a significant milestone by securing a Global Supplier Agreement with Arjohuntleigh Polska Sp. z o.o., marking its entry into the global healthcare supply chain. The agreement, announced on February 05, 2026, follows a comprehensive year-long validation process and approvals, positioning the company as a trusted supplier to one of the world's leading medical equipment manufacturers.

Strategic Partnership with Global Healthcare Leader

The agreement establishes Mitsu Chem Plast Limited as a global supplier to the Arjo Group, recognized as one of the world's Top 5 leading medical equipment companies. This partnership reflects the company's strong manufacturing capabilities, professional approach, consistent quality standards, and compliance with international requirements.

Product Portfolio and Healthcare Applications

Under the new agreement, Mitsu Chem Plast will supply hospital furniture parts and other related plastic accessories. These specialized products are designed to support critical healthcare functions including patient safety, caregiver ergonomics, and efficient risk management in the healthcare industry. The partnership leverages Mitsu's expertise in polymer-based molded products and technical manufacturing capabilities.

Business Impact and Growth Opportunities

The partnership creates multiple strategic advantages for Mitsu Chem Plast Limited. It strengthens the company's presence in the global furniture parts supply chain while enhancing brand visibility across international markets. The agreement also generates long-term growth opportunities by expanding the company's hospital furniture parts portfolio and supporting export-led business growth initiatives.

Market Context and Trade Relations

The engagement coincides with strengthening India-European Union trade relations, supported by the recently concluded India-EU trade agreement. This development is expected to improve export competitiveness and ease market access for specialized polymer and healthcare component manufacturers, thereby supporting Mitsu Chem Plast's long-term international business expansion strategy.

Management Commentary

Mr. Sanjay Dedhia, Managing Director of Mitsu Chem Plast Limited, expressed satisfaction with the development, stating that successfully completing the year-long validation process reflects the strength of the company's product quality, manufacturing discipline, and ability to meet stringent global standards. He emphasized that this partnership positions Mitsu as a trusted supplier in the global healthcare ecosystem and supports the company's strategy of expanding exports, diversifying the customer base, and building sustainable relationships with global leaders.

Company Performance Overview

Mitsu Chem Plast Limited operates as a certified manufacturer of polymer-based molded products, serving diverse industries including Industrial Packaging Solutions, Healthcare Products, Infrastructure Products, and Emergency Handling Solutions. The company operates four manufacturing facilities in Maharashtra, with three plants in Boisar, Tarapur, and one in Khalapur, supported by robust in-house testing and quality control systems.